SENIOR LEADERSHIP

高层领导

基本信息

  • 批准号:
    8532363
  • 负责人:
  • 金额:
    $ 7.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-14 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

7.1 Senior Leadership Director: C. Kent Osborne M.D. Dr Osborne has committed 6.00 calendar months effort to serve as Cancer Center Director. As Director his responsibilities include: 1. Oversee cancer-related clinical and research activities at BCMCC. 2. Promote interdisciplinary coordination and collaboration. 3. Facilitate interactions and collaborations with other medical institutions and cancer centers. 4. Organize and oversee the Shared Resources ofthe Cancer Center, create new Shared Resources, or eliminate obsolete Resources as necessary to best carry out the Cancer Center's mission and goals. 5. Develop and manage the Cancer Center's budget and its philanthropic gifts. 6. Recruit new faculty in cooperation with Department Chairs to enhance the mission of the Cancer Center. 7. Allocate Cancer Center space, approve membership applications, and represent the Cancer Center on the College's Academic Council and on the Executive Committee ofthe Baylor Clinic. Dr. Osborne holds the Dudley and Tina Sharp Chair for Cancer Research and is also the Director of the Breast Center. He received his M.D. degree from the University of Missouri School of Medicine in 1972, followed by internal medicine training at Johns Hopkins, and a medical oncology fellowship at the National Cancer Institute. He then moved to the University of Texas Health Science Center at San Antonio in 1977 where he and his late colleague, William McGuire, M.D., built an internationally recognized breast cancer program. Dr. Osborne rose to be Professor of Medicine and the Director of the Division of Oncology and Program Leader of the Breast Cancer Program at the Cancer Center at that institution. In 1999, he and his group moved to Baylor College of Medicine to create a Breast Center in Houston. Dr. Osborne is a Board Certified Medical Oncologist who has been specializing in breast cancer for more than 25 years. He is also a well recognized translational scientist, and his laboratory has been continuously funded since 1978. He is recognized for his work on estrogen receptor function, mechanisms of resistance to endocrine therapy, and crosstalk between ER and growth factor receptor pathways. He has more than 300 publications in his career and has received many awards for his research. Dr. Osborne has been the principal investigator of a Program Project Grant in breast cancer that has been continuously funded since 1980. He is also the principal investigator on a breast cancer SPORE grant that has been continuously funded since 1992. He has relinquished his role as principal investigator of the PPG to a colleague in order to be able to devote more time to directing the Cancer Center. He will still have a roie in the research program of the PPG. Dr. Osborne has considerable administrative experience. He was chair of the Breast Committee for the Southwest Oncology Group for many years and was one of the founding members of the Intergroup Breast Committee, which oversees the major phase 3 breast cancer trials performed in this country. He was the Director of the Division of Medical Oncology at the UT Health Science Center at San Antonio for 7 years prior to moving to Houston to become Director of the Breast Center. He has served on numerous local, national, and international committees, and for 17 years has been co-director of the San Antonio Breast Cancer Symposium, the largest annual symposium devoted to breast cancer research, now attracting more than 9000 attendees from over 80 countries. He previously served as Executive Officer for the Southwest Oncology Group. He was a member of the American Society of Clinical Oncology Board of Directors from 1992-1995 and their Executive Committee from 1994-1997. Dr. Osborne has served on the External Advisory Boards of several Cancer Centers and was a member of the NIH Reproductive Endocrinology Study Section.
7.1高级领导 导演:C.肯特奥斯本医学博士 奥斯本博士已承诺6.00日历月的努力,担任癌症中心主任。作为董事,他的职责包括: 1.监督BCMCC的癌症相关临床和研究活动。 2.促进跨学科协调与合作。 3.促进与其他医疗机构和癌症中心的互动和合作。 4.组织和监督癌症中心的共享资源,创建新的共享资源,或根据需要淘汰过时的资源,以最好地执行癌症中心的使命和目标。 5.制定和管理癌症中心的预算和慈善捐赠。 6.与系主任合作招募新的教师,以加强癌症中心的使命。 7.分配癌症中心的空间,批准会员申请,并代表癌症中心在学院的学术理事会和贝勒诊所的执行委员会。 博士奥斯本拥有癌症研究的达德利和蒂娜夏普主席,也是乳腺中心的主任。他获得了医学博士学位。1972年获得密苏里州医学院学位,随后在约翰霍普金斯接受内科培训,并在国家癌症研究所获得医学肿瘤学奖学金。 1977年,他搬到了位于圣安东尼奥的德克萨斯大学健康科学中心,在那里他和他已故的同事威廉·麦奎尔医学博士,建立了一个国际公认的乳腺癌项目。奥斯本上升到医学教授和肿瘤学主任和乳腺癌计划在该机构的癌症中心的项目负责人。1999年,他和他的团队搬到了贝勒大学。 医学在休斯顿建立一个乳房中心。Osborne博士是一位委员会认证的医学肿瘤学家,专门研究乳腺癌超过25年。他也是一位公认的翻译科学家,他的实验室自1978年以来一直得到资助。他因其在雌激素受体功能、内分泌治疗抵抗机制以及ER和生长因子受体途径之间的串扰方面的工作而受到认可。他在职业生涯中发表了300多篇论文,并因其研究获得了许多奖项。Osborne博士是自1980年以来一直获得资助的乳腺癌计划项目赠款的主要研究者。他也是自1992年以来一直持续资助的乳腺癌SPORE补助金的主要研究员。他已经放弃了PPG的主要研究者的角色,以便能够投入更多的时间来指导癌症中心。他仍将 在PPG的研究计划中发挥作用。 博士奥斯本拥有丰富的行政经验。他曾担任西南肿瘤学小组乳腺委员会主席多年,也是小组间乳腺委员会的创始成员之一,该委员会负责监督在该国进行的主要3期乳腺癌试验。在此之前,他曾在位于圣安东尼奥的UT健康科学中心担任肿瘤内科主任7年 搬到休斯顿成为乳腺中心的主任他曾在许多地方、国家和国际委员会任职,17年来一直担任圣安东尼奥乳腺癌研讨会的联合主任,该研讨会是致力于乳腺癌研究的最大的年度研讨会,目前吸引了来自80多个国家的9000多名与会者。他曾担任西南肿瘤组的执行官。1992-1995年,他是美国临床肿瘤学会董事会成员,1994-1997年是其执行委员会成员。Osborne博士曾在多个癌症中心的外部咨询委员会任职,也是NIH生殖内分泌研究科的成员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

C KENT OSBORNE其他文献

C KENT OSBORNE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('C KENT OSBORNE', 18)}}的其他基金

Translational Research in Breast Cancer (SPORE)
乳腺癌转化研究 (SPORE)
  • 批准号:
    8738883
  • 财政年份:
    2014
  • 资助金额:
    $ 7.5万
  • 项目类别:
Translational Research in Breast Cancer (SPORE)
乳腺癌转化研究 (SPORE)
  • 批准号:
    9332107
  • 财政年份:
    2014
  • 资助金额:
    $ 7.5万
  • 项目类别:
Translational Research in Breast Cancer (SPORE)
乳腺癌转化研究 (SPORE)
  • 批准号:
    9127157
  • 财政年份:
    2014
  • 资助金额:
    $ 7.5万
  • 项目类别:
Translational Research in Breast Cancer (SPORE)
乳腺癌转化研究 (SPORE)
  • 批准号:
    9338859
  • 财政年份:
    2014
  • 资助金额:
    $ 7.5万
  • 项目类别:
CTRP Supplement
CTRP 补充
  • 批准号:
    8761944
  • 财政年份:
    2013
  • 资助金额:
    $ 7.5万
  • 项目类别:
CTLA Supplement
CTLA 补充品
  • 批准号:
    8761960
  • 财政年份:
    2013
  • 资助金额:
    $ 7.5万
  • 项目类别:
SENIOR LEADERSHIP
高层领导
  • 批准号:
    8180895
  • 财政年份:
    2010
  • 资助金额:
    $ 7.5万
  • 项目类别:
Project Planning and Evaluation
项目规划与评估
  • 批准号:
    8180901
  • 财政年份:
    2010
  • 资助金额:
    $ 7.5万
  • 项目类别:
DEVELOPMENTAL FUNDS
发展基金
  • 批准号:
    8181052
  • 财政年份:
    2010
  • 资助金额:
    $ 7.5万
  • 项目类别:
PROGRAM LEADERS
项目负责人
  • 批准号:
    8180907
  • 财政年份:
    2010
  • 资助金额:
    $ 7.5万
  • 项目类别:

相似海外基金

NSF Engines Development Award: Utilizing space research, development and manufacturing to improve the human condition (OH)
NSF 发动机发展奖:利用太空研究、开发和制造来改善人类状况(OH)
  • 批准号:
    2314750
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Cooperative Agreement
NSF Engines Development Award: Building an sustainable plastics innovation ecosystem in the Midwest (MN, IL)
NSF 引擎发展奖:在中西部(明尼苏达州、伊利诺伊州)建立可持续塑料创新生态系统
  • 批准号:
    2315247
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Cooperative Agreement
NSF Engines Development Award: Creating climate-resilient opportunities for plant systems (NC)
NSF 发动机开发奖:为工厂系统创造气候适应机会 (NC)
  • 批准号:
    2315399
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Cooperative Agreement
International Partnering Award: Using AI to assess senescence and mitochondrial morphology in calcifying VSMCs
国际合作奖:利用人工智能评估钙化 VSMC 的衰老和线粒体形态
  • 批准号:
    BB/Y513982/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Durham University
2024 年开放访问区块奖 - 杜伦大学
  • 批准号:
    EP/Z531480/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Goldsmiths College
2024 年开放获取区块奖 - 金史密斯学院
  • 批准号:
    EP/Z531509/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - John Innes Centre
2024 年开放访问区块奖 - 约翰·英尼斯中心
  • 批准号:
    EP/Z53156X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - London School of Economics & Pol Sci
2024 年开放获取区块奖 - 伦敦政治经济学院
  • 批准号:
    EP/Z531625/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - Oxford Brookes University
2024 年开放获取区块奖 - 牛津布鲁克斯大学
  • 批准号:
    EP/Z531728/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
Open Access Block Award 2024 - The Francis Crick Institute
2024 年开放获取区块奖 - 弗朗西斯·克里克研究所
  • 批准号:
    EP/Z531844/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了